Immunoglobulin and autoantibody responses in MRL/lpr mice treated with 'toxic oils'

Toxicology

Volumn 178, Issue 2, 2002, Pages 119-133

  Koller, Loren D ^a   Stang, Bernadette V ^a   Hall, Jean A ^a   Posada De La Paz, Manuel ^b   Ruiz Mendez, Maria V ^c  

^a OREGON STATE UNIVERSITY   (United States)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE LA GRASA   (Spain)

Author keywords

Autoantibody; Autoimmunity; Mercury; MRL lpr mice; Toxic oil syndrome

Indexed keywords

3 (N PHENYLAMINO) 1,2 PROPANEDIOL; ALKANEDIOL DERIVATIVE; AUTOANTIBODY; IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; BIOSYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENATURATION; DILUTION; DISEASE COURSE; IMMUNE RESPONSE; IMMUNOREACTIVITY; LYMPHOPROLIFERATIVE DISEASE; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RACEMIC MIXTURE; TOXIC OIL SYNDROME;

ANILINE COMPOUNDS; ANIMALS; AUTOANTIBODIES; BODY WEIGHT; BRASSICA RAPA; DNA; DNA, SINGLE-STRANDED; FEMALE; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; MICE; MICE, INBRED MRL LPR; ORGAN SIZE; PLANT OILS; SPLEEN; THYMUS GLAND;

ANIMALIA; BRASSICA NAPUS VAR. NAPUS; SINAPIS ARVENSIS; TOSCANA VIRUS;

EID: 0037009218     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00232-9     Document Type: Article

References (74)

1. Molecular mimicry and autoimmunity
2. Toxic oil syndrome: A syndrome with features overlapping those of various forms of scleroderma
3. Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients
4. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains
5. Glomerular basement-membrane antibodies and HLA-DR2 in spanish rapeseed oil disease
6. Immune reactions responsible for autoimmune diseases have multiple targets
7. IL12 down-regulates autoantibody protection in mercury-induced autoimmunity
8. Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome
9. Involvement of nuclear factor-κB in a murine model for the acute form of autoimmune-like toxic oil syndrome
10. The acute pathology of fatty acid anilides and linoleic diester of 3-phenylomino-1, 2-propanediol in mice: Possible implication as etiologic agents for the toxic oil syndrome
11. Strain-dependent cytokine profile and susceptibility to oleic acid anilide in a murine model of the toxic oil syndrome
12. Autoimmunity caused by xenobiotics
13. +T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis
14. Dietary fatty acids and the immune system
15. Health status measurements in toxic oil syndrome
16. Oil ingestion and the toxic-oil syndrome: Results of a survey of residents of the Orcasur neighborhood in Marid, Spain
17. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease
18. The lpr and gld genes in systemic autoimmunity: Life and death in the fast lane
19. Cytokine mRNA expression in lung tissue from toxic oil syndrome patients: A Th2 immunological mechanism
20. The association of oil ingestion with toxic-oil syndrome in two convents
21. d mice is mediated by interferon-gamma
22. Genetic risk factors for autoimmune diseases
23. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL/lpr mice
24. Immunological basis of toxic oil syndrome (TOS)
25. Review of investigations and findings
26. Possible etiologic agents for toxic oil syndrome: Fatty acid esters of 3-(N-phenylamino)-1,2-propanediol
27. Non-responsiveness to mercury-induced autoimmunity in resistant DBA/2 mice is not due to immunosuppression or biased Th1-type response
28. Mechanism of mercury-induced autoimmunity: Both T helper 1- and T helper 2-type responses are involved
29. Antifibrillarin antibodies in mercury-treated mice
30. Murine susceptibility to mercury I. Autoantibody profiles and systemic immune deposits in inbred, and intra-H-2-recombinant strains
31. Murine susceptibility to mercury II. Autoantibody profiles and renal immune deposits in hybrid, backcross, and H-2d congenic mice
32. Murine mercury-induced autoimmunity: The importance of T cells
33. The effect of toxicokinetics on murine mercury-induced autoimmunity
34. 2
35. The genotype determines the B cell response in mercury-treated mice
36. Tolerance and autoimmunity
37. Molecular mimicry between non-self, modified self, and self in autoimmunity
38. Pathology of selected 'toxic oils' and selected metals in the MRL/lpr mouse
39. The prototype Th2 autoimmunity induced by mercury is dependent on IFN-γ and not Th1/Th2 imbalance
40. Distinct levels of regulation in organ-specific autoimmune diseases
41. Immunological aspects of the toxic oil syndrome
42. The genetics of systemic lupus erythematosus
43. MRL/lpr mice exhibit a defect in maintaining developmental arrest of follicular exclusion of anti-double-stranded DNA B cells
44. Detective CD95/AP0-1/Fas signal complex formation in the human autoimmune lymphopreliferative syndrome, type Ia
45. Mercury: God of Th2 cells
46. The role of autoantigens in autoimmune disease
47. Fas/AP0-1/CD95 in health and autoimmune disease: Thymic and peripheral aspects
48. Systemic mononuclear cell vasculitis in MRL/MP-lpr/lpr mice: A histopathological and immunocytochemical analysis
49. Cell death control in lymphocytes
50. Toxic epidemic syndrome: Spain 1981
51. Arteritis in a novel congenic strain of mice derived from MRL/lpr lupus mice
52. IL4 is required for the IgE and IgG1 autoantibody formation in mice treated with mercuric chloride
53. Collagen antibodies in toxic oil disease
54. Specificity and idiotypic analysis of a monoclonal anti-Sm antibody with α-DNA activity
55. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity
56. Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone BXSB mice
57. Toxic-oil syndrome case reports associated with the ITH Oil Refinery in Sevilla
58. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain
59. Epidemiologic evidence for a new class of compounds associated with toxic oil syndrome
60. Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice
61. The role of infection in the pathogenesis of autoimmune disease
62. Enzyme linked immunosorbent assay for anti-DNA and antihistone antibodies
63. Role of Fas/FasL interaction in physiology and pathology: The good and the bad
64. Products of aniline and triglycerides in oil samples associated with the toxic oil syndrome
65. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity
66. Lpr T cells are necessary for autoantibody production in lpr mice
67. Monoclonal antibody production in gas-permiable flexible flasks using serum-free media
68. Why do defects in the Fas-Fas ligand system cause autoimmunity
69. Toxic allergic syndrome caused by ingestion of rapeseed oil denatured with aniline
70. Murine models of systemic lupus erythematosus
71. Apoptosis in the pathogenesis and treatment of disease
72. The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/AP0-1) mutations
73. Genetic analysis of MRL/lpr mice: Relationship of the Fas apoptosis gene to disease manifestation and renal disease-modifying loci
74. The toxic oil syndrome: A perspective on immunological mechanisms